{
    "2021-03-08": [
        [
            {
                "time": "2023-10-16",
                "original_text": "基金赎回潮来临？基金公司渠道人士回应",
                "features": {
                    "keywords": [
                        "基金",
                        "赎回潮",
                        "渠道"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "药明康德(603259.SH)拟参股药明汇聚及苏州群英拓宽生态圈",
                "features": {
                    "keywords": [
                        "药明康德",
                        "参股",
                        "生态圈"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "药明康德(603259.SH)拟参与设立基金管理公司及基金普通合伙人",
                "features": {
                    "keywords": [
                        "药明康德",
                        "基金管理公司",
                        "基金"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "药明康德(603259)：全年业绩超预期 中国区及CDMO业务增长强劲",
                "features": {
                    "keywords": [
                        "药明康德",
                        "业绩",
                        "CDMO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "两知名药企联手，进军糖尿病创新药领域",
                "features": {
                    "keywords": [
                        "药企",
                        "糖尿病",
                        "创新药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "智通每日大行研报︱中国宏桥(01378)绩后获机构齐升目标价 野村、瑞银重申药明康德(02359)“买入”评级",
                "features": {
                    "keywords": [
                        "药明康德",
                        "买入",
                        "评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "医药生物行业周报：新医保目录开始启用 关注结构性变化下的投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保目录",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "A股收盘综述：上证指数下滑2.3%，创业板指跌入技术性熊市",
                "features": {
                    "keywords": [
                        "A股",
                        "上证指数",
                        "创业板指"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "通化东宝与药明康德达成合作 开发糖尿病治疗领域创新药物",
                "features": {
                    "keywords": [
                        "通化东宝",
                        "药明康德",
                        "糖尿病",
                        "创新药物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "五粮液、恒瑞医药、智飞生物、药明康德、中联重科、金龙鱼等均下挫逾7%",
                "features": {
                    "keywords": [
                        "五粮液",
                        "恒瑞医药",
                        "药明康德",
                        "下挫"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}